Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03952767 · ClinicalTrials.gov registry record · NA
The STEPP Study: Sensors To Evaluate Physical Performance
A NA study of Oncology, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT03952767: Completed NA study of Oncology, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT03952767 is a NA study of Oncology that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 63 participants, below the 525-participant average among 24 other Oncology trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03952767, a NA study of Oncology, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
This study assesses the association between digital functional measures of physical and patient-reported standard onocological assessments, like Karnofsky Performance Score (KPS).
Primary Outcome
At-home record of mean steps per day
Conditions Studied
Interventions
- OTHER Digital Physical Measures and Survey Assessments
Study Locations (1)
North Carolina
- UNC Lineberger Comprehensive Cancer Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2019-04-24 |
| Est. Completion | 2022-08-30 |
| Phase | NA |
What the finished NCT03952767 record still lists
NCT03952767 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 525-participant average among 24 other Oncology trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Oncology appearing as the primary indexed condition, and to 1 intervention - of which Digital Physical Measures and Survey Assessments is the first listed.
NCT03952767 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03952767 about?
NCT03952767 is a clinical study titled "The STEPP Study: Sensors To Evaluate Physical Performance". This study assesses the association between digital functional measures of physical and patient-reported standard onocological assessments, like Karnofsky Performance Score (KPS).
What is the current status of trial NCT03952767?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2019-04-24. Estimated completion is 2022-08-30.
What conditions does trial NCT03952767 study?
This clinical trial studies the following conditions: Oncology.
What interventions are being tested in trial NCT03952767?
The interventions under investigation include: Digital Physical Measures and Survey Assessments (OTHER).
Who is sponsoring clinical trial NCT03952767?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03952767 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oncology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03952767's enrollment target sits among peer trials
63 15th of 24 higher than 8 of 24 other Oncology trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oncology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Leading Healthy Eating and Activity Promotion Program
RECRUITING · NA
-
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
RECRUITING · NA
-
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
RECRUITING · NA
-
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI